Summary

Lonza Group Ltd (Lonza) is a chemical and biotechnology company, founded in 1897. The company operates its business activities in three divisions: Life Science Ingredients, Exclusive Synthesis and Biopharmaceuticals, and Bioscience. The company offers 3,500 products and services to more than 14,000 customers worldwide. It is headquartered at Basel, Switzerland and employs 7,711 people. 

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Lonza Group Ltd. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct’s views on the company.

Scope

-The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. 
-The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

-A quick “one-stop-shop” to understand the company. 
-Enhance business/sales activities by understanding customers’ businesses better.
-Get detailed information and financial & strategic analysis on companies operating in your industry.
-Identify prospective partners and suppliers – with key data on their businesses and locations.
-Capitalize on competitors’ weaknesses and target the market opportunities available to them.
-Compare your company’s financial trends with those of your peers / competitors.
-Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Key Information  1
Key Ratios  1
Share Data  1
Performance Chart  1
Table Of Contents  2
List of Tables  3
List of Figures  3
Key Facts  4
Business Description  4
Major Products and Services  5
Overview  5
History  8
SWOT Analysis Overview  9
Overview  9
Lonza Group Ltd - Strengths  9
Financial Strength  9
Resolute Research and Development  9
Integrated System  9
Lonza Group Ltd - Weaknesses  9
Patent Infringement  9
Divestitures  9
Lonza Group Ltd - Opportunities  9
On-going Pipeline Activities  9
Amaxa Acquisition  9
Long-term Agreements  10
Lonza Group Ltd - Threats  10
Impact of Pharmaceuticals Regulations  10
Product Risk  10
Uncertainties in R&D  10
Key Competitors  11
Key Employees  11
Key Employee Biographies  12
Company Statement  13
Locations And Subsidiaries  15
Head Office  15
Other Locations & Subsidiaries  15
Financial Ratios  17
Capital Market Ratios  17
Annual Ratios  17
Interim Ratios  18
Ratio Charts  19
Appendix  20
Methodology  20
Ratio Definitions  20
About Global Markets Direct  23
Contact Us  23
Disclaimer  23

List of Tables 

Lonza Group Ltd, Key Facts  1
Lonza Group Ltd, Key Ratios  1
Lonza Group Ltd, Share Data  1
Lonza Group Ltd, Key Facts  4
Major Products and Services  5
Lonza Group Ltd, History  8
Lonza Group Ltd, Key Employees  11
Lonza Group Ltd, Key Employee Biographies  12
Lonza Group Ltd, Subsidiaries  15
Lonza Group Ltd, Ratios based on current share price  17
Lonza Group Ltd, Annual Ratios  17
Lonza Group Ltd, Interim Ratios  18
Currency Codes  20
Capital Market Ratios  20
Equity Ratios  20
Profitability Ratios  21
Cost Ratios  21
Liquidity Ratios  21
Leverage Ratios  22
Efficiency Ratios  22

List of Figures 

Lonza Group Ltd, Performance Chart (2004 - 2008)  1
Lonza Group Ltd, Ratio Charts  19